Literature DB >> 1850493

Cholera toxin and pertussis toxin on opioid- and alpha 2-mediated supraspinal analgesia in mice.

P Sánchez-Blázquez1, J Garzón.   

Abstract

Cholera toxin, an agent that impairs the function of Gs transducer proteins, was injected (0.5 microgram/mouse, icv) and the antinociceptive activity of opioids and clonidine was studied 24h later in the tail-flick test. In these animals, an enhancement of the analgesic potency of morphine, beta-endorphin and clonidine could be observed. Cholera toxin did not modify the antinociception evoked by the enkephalin derivatives DAGO and DADLE. Pertussis toxin that catalyses the ADP ribosylation of alpha subunits of Gi/Go regulatory proteins was given icv (0.5 microgram/mouse). This treatment reduced the analgesic effect of opioids and clonidine. However, while the analgesia elicited by DAGO, DADLE and clonidine was greatly decreased, the effect of morphine and beta-endorphin was reduced to a moderate extent. It is concluded that Gi/Go regulatory proteins functionally coupled to opioid and alpha 2 receptors are implicated in the efficacy displayed by opioids and clonidine to produce supraspinal analgesia. Moreover, these two receptors are susceptible to regulation by a process that might involve a Gs protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850493     DOI: 10.1016/0024-3205(91)90208-s

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Influence of pertussis toxin on the calcitonin-opioid interaction in isolated tissues.

Authors:  M I Martin; C Goicoechea; M J Ormazábal; M J Alfaro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Effects of intrathecal or intracerebroventricular pretreatment with pertussis toxin on antinociception induced by beta-endorphin or morphine administered intracerebroventricularly in mice.

Authors:  K M Chung; D K Song; H W Suh; M H Lee; Y H Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

3.  Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.

Authors:  L C Stanfa; A H Dickenson
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors.

Authors:  N Galeotti; C Ghelardini; M C Vinci; A Bartolini
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs.

Authors:  M Ocaña; E Del Pozo; M Barrios; J M Baeyens
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.